Altered glycosylation in progression and management of bladder cancer

M Wilczak, M Surman, M Przybyło - Molecules, 2023 - mdpi.com
Bladder cancer (BC) is the 10th most common malignancy worldwide, with an estimated
573,000 new cases and 213,000 deaths in 2020. Available therapeutic approaches are still …

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion

C Gaiteiro, J Soares, M Relvas-Santos… - …, 2022 - pmc.ncbi.nlm.nih.gov
Rationale: Bladder cancer (BC) management demands the introduction of novel molecular
targets for precision medicine. Cell surface glycoprotein CD44 has been widely studied as a …

Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach

A Aayush, S Darji, KM Estes, E Yeh… - …, 2024 - ACS Publications
Nucleic acid (NA)-based therapies are revolutionizing biomedical research through their
ability to control cellular functions at the genetic level. This work demonstrates a versatile …

Integrated Metabolomics and Transcriptomic Analysis of Hepatopancreas in Different Living Status Macrobrachium nipponense in Response to Hypoxia

L Xu, W Zhang, H Qiao, S Jiang, Y **ong, S **, Y Gong… - Antioxidants, 2021 - mdpi.com
As the basic element of aerobic animal life, oxygen participates in most physiological
activities of animals. Hypoxia stress is often the subject of aquatic animal research …

Neolactotetraosylceramide: A novel non-invasive urinary biomarker for bladder cancer

IB Moreira, C Rossdam, J Beimdiek, MM Vicente… - bioRxiv, 2023 - biorxiv.org
There is an urgent need to identify noninvasive biomarkers for bladder cancer. Here, we
applied glycan analytics by multiplex capillary gel electrophoresis coupled to laser-induced …

Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion

C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto… - bioRxiv, 2021 - biorxiv.org
Bladder cancer (BC) management demands the introduction of novel molecular targets for
precision medicine. Cell surface glycoprotein CD44 has been widely studied as a potential …